Arcadia Biosciences, Inc. (RKDA)
USD 5.87
(-0.51%)
USD 5.87
(-0.51%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 2.03 Million USD | 1218.18% |
| 2022 | 154 Thousand USD | 107.99% |
| 2021 | -1.92 Million USD | -168.01% |
| 2020 | 2.83 Million USD | 898.24% |
| 2019 | 284 Thousand USD | -64.63% |
| 2018 | 803 Thousand USD | -78.55% |
| 2017 | 3.74 Million USD | 63.24% |
| 2016 | 2.29 Million USD | -49.29% |
| 2015 | 4.52 Million USD | -9.29% |
| 2014 | 4.98 Million USD | -14.13% |
| 2013 | 5.8 Million USD | -4.85% |
| 2012 | 6.1 Million USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 435 Thousand USD | -13.0% |
| 2024 Q2 | 673 Thousand USD | 54.71% |
| 2023 Q3 | 495 Thousand USD | 21.32% |
| 2023 Q2 | 408 Thousand USD | -40.35% |
| 2023 FY | 2.03 Million USD | 1218.18% |
| 2023 Q1 | 684 Thousand USD | 223.91% |
| 2023 Q4 | 500 Thousand USD | 1.01% |
| 2022 Q1 | -238 Thousand USD | 84.97% |
| 2022 Q2 | 411 Thousand USD | 272.69% |
| 2022 Q3 | 534 Thousand USD | 29.93% |
| 2022 FY | 154 Thousand USD | 107.99% |
| 2022 Q4 | -552 Thousand USD | -203.37% |
| 2021 Q3 | -135 Thousand USD | 25.82% |
| 2021 Q1 | -28 Thousand USD | -100.52% |
| 2021 FY | -1.92 Million USD | -168.01% |
| 2021 Q4 | -1.58 Million USD | -1072.59% |
| 2021 Q2 | -182 Thousand USD | -550.0% |
| 2020 Q2 | -1.2 Million USD | -783.05% |
| 2020 FY | 2.83 Million USD | 898.24% |
| 2020 Q4 | 5.39 Million USD | 453.24% |
| 2020 Q3 | -1.52 Million USD | -26.3% |
| 2020 Q1 | 177 Thousand USD | 222.07% |
| 2019 FY | 284 Thousand USD | -64.63% |
| 2019 Q3 | 215 Thousand USD | 88.6% |
| 2019 Q4 | -145 Thousand USD | -167.44% |
| 2019 Q1 | 99 Thousand USD | -53.74% |
| 2019 Q2 | 114 Thousand USD | 15.15% |
| 2018 Q1 | 178 Thousand USD | -87.35% |
| 2018 FY | 803 Thousand USD | -78.55% |
| 2018 Q4 | 214 Thousand USD | -13.01% |
| 2018 Q2 | 165 Thousand USD | -7.3% |
| 2018 Q3 | 246 Thousand USD | 49.09% |
| 2017 FY | 3.74 Million USD | 63.24% |
| 2017 Q1 | 912 Thousand USD | 907.08% |
| 2017 Q2 | 875 Thousand USD | -4.06% |
| 2017 Q3 | 549 Thousand USD | -37.26% |
| 2017 Q4 | 1.4 Million USD | 156.28% |
| 2016 Q1 | 705 Thousand USD | 4.14% |
| 2016 FY | 2.29 Million USD | -49.29% |
| 2016 Q4 | -113 Thousand USD | -111.13% |
| 2016 Q3 | 1.01 Million USD | 47.96% |
| 2016 Q2 | 686 Thousand USD | -2.7% |
| 2015 FY | 4.52 Million USD | -9.29% |
| 2015 Q3 | 1.76 Million USD | 33.08% |
| 2015 Q2 | 1.32 Million USD | 74.44% |
| 2015 Q1 | 759 Thousand USD | -72.23% |
| 2015 Q4 | 677 Thousand USD | -61.58% |
| 2014 Q1 | 1.28 Million USD | -32.85% |
| 2014 Q2 | 1.25 Million USD | -2.1% |
| 2014 Q3 | -293 Thousand USD | -123.27% |
| 2014 FY | 4.98 Million USD | -14.13% |
| 2014 Q4 | 2.73 Million USD | 1032.76% |
| 2013 FY | 5.8 Million USD | -4.85% |
| 2013 Q4 | 1.91 Million USD | 375.54% |
| 2013 Q3 | -695 Thousand USD | 14.93% |
| 2013 Q1 | -817 Thousand USD | 0.0% |
| 2013 Q2 | -817 Thousand USD | 0.0% |
| 2012 FY | 6.1 Million USD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Bioceres Crop Solutions Corp. | 182.43 Million USD | 98.887% |
| Muliang Viagoo Technology, Inc. | 3.3 Million USD | 38.547% |
| N2OFF, Inc. | 208.26 Thousand USD | -874.71% |
| Yield10 Bioscience, Inc. | -230 Thousand USD | 982.609% |